(Q34323219)

1 August 2017

1 reference

title

Hepatitis B and hepatitis C co-infection in patients with HIV. (English)

1 reference

1 August 2017

1 reference

1 reference

Herrero Martínez E

1

1 reference

1 August 2017

language of work or name

1 reference

1 July 2001

1 reference

Reviews in Medical Virology

1 August 2017

published in

1 reference

1 August 2017

volume

11

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

253-270

1 reference

Natural and iatrogenic variation in hepatitis B virus

1 August 2017

cites work

1 reference

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

21 January 2018

1 reference

Hepatitis B: Evolving Epidemiology and Implications for Control

21 January 2018

1 reference

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection

21 January 2018

1 reference

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

21 January 2018

1 reference

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

21 January 2018

1 reference

Intrahepatic T cells in hepatitis B: viral control versus liver cell injury

21 January 2018

1 reference

Molecular virology and pathogenesis of hepatitis B.

21 January 2018

1 reference

To kill or to cure: options in host defense against viral infection.

21 January 2018

1 reference

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

21 January 2018

1 reference

Hepatitis B virus. The major etiology of hepatocellular carcinoma

21 January 2018

1 reference

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

21 January 2018

1 reference

Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice

21 January 2018

1 reference

The hepatitis B virus X gene induces p53-mediated programmed cell death

21 January 2018

1 reference

Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis

21 January 2018

1 reference

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

21 January 2018

1 reference

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

21 January 2018

1 reference

Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group

21 January 2018

1 reference

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

21 January 2018

1 reference

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

21 January 2018

1 reference

Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.

21 January 2018

1 reference

Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha

21 January 2018

1 reference

Coinfection and superinfection of hepatitis B virus in patients infected with human immunodeficiency virus: no evidence of faster progression to AIDS.

21 January 2018

1 reference

The prevalence of hepatitis B and C in HIV-positive Greek patients: relationship to survival of deceased AIDS patients

21 January 2018

1 reference

Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection

21 January 2018

1 reference

HBsAg as the antigen component of circulating immune complexes in HIV-infected patients.

21 January 2018

1 reference

HIV and Hepatitis Virus Infection

21 January 2018

1 reference

Novel compounds in preclinical/early clinical development for the treatment of HIV infections

21 January 2018

1 reference

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy

21 January 2018

1 reference

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

21 January 2018

1 reference

Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

Replication of hepatitis C virus

21 January 2018

1 reference

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

21 January 2018

1 reference

The epidemiology of antibody to hepatitis C in Egypt

21 January 2018

1 reference

Epidemiology of hepatitis C in the United States.

21 January 2018

1 reference

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

Detection of hepatitis C virus in the semen of infected men.

21 January 2018

1 reference

Antibody to Hepatitis C Virus among Cardiac Surgery Patients, Homosexual Men, and Intravenous Drug Users in Baltimore, Maryland

21 January 2018

1 reference

Virus load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis C virus by men with hemophilia. The Multicenter Hemophilia Cohort Study

21 January 2018

1 reference

Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women

21 January 2018

1 reference

Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

21 January 2018

1 reference

Hepatitis C virus infection in spouses of patients with type C chronic liver disease.

21 January 2018

1 reference

Hepatitis C virus infection in sexually promiscuous groups

21 January 2018

1 reference

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus-specific CD4(+) T cells: do they help or damage?

21 January 2018

1 reference

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

21 January 2018

1 reference

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus

21 January 2018

1 reference

Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients

21 January 2018

1 reference

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

21 January 2018

1 reference

Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection

21 January 2018

1 reference

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

21 January 2018

1 reference

Immunopathogenesis of hepatitis C virus infection

21 January 2018

1 reference

Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection

21 January 2018

1 reference

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

21 January 2018

1 reference

Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepat

21 January 2018

1 reference

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

21 January 2018

1 reference

Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.

21 January 2018

1 reference

The role of the hepatitis C virus glycoproteins in infection.

21 January 2018

1 reference

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV).

21 January 2018

1 reference

Non-A, non-B post-transfusion hepatitis. Looking back in the second decade

21 January 2018

1 reference

The long-term pathological evolution of chronic hepatitis C.

21 January 2018

1 reference

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

45-year follow-up of hepatitis C virus infection in healthy young adults

21 January 2018

1 reference

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

21 January 2018

1 reference

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

21 January 2018

1 reference

The response to interferon + ribavirin re-treatment for chronic hepatitis C in interferon non-responders is not influenced by race

21 January 2018

1 reference

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

21 January 2018

1 reference

Treatment of hepatitis C with interferon and ribavirin

21 January 2018

1 reference

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report

21 January 2018

1 reference

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

21 January 2018

1 reference

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

Hepatitis C viraemia in HIV-HCV co-infected patients having immune restoration with highly active antiretroviral therapy.

21 January 2018

1 reference

Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection

21 January 2018

1 reference

Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy

21 January 2018

1 reference

Change in transaminases in hepatitis C virus- and HIV-coinfected patients after highly active antiretroviral therapy: differences between complete and partial virologic responders?

21 January 2018

1 reference

Can HCV affect the efficacy of anti-HIV treatment?

21 January 2018

1 reference

The progression of HCV-associated liver disease in a cohort of haemophilic patients

21 January 2018

1 reference

Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters

21 January 2018

1 reference

Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus

21 January 2018

1 reference

The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985

21 January 2018

1 reference

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

21 January 2018

1 reference

Detection of hepatitis C virus RNA sequences in B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells

21 January 2018

1 reference

The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity

21 January 2018

1 reference

Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment

21 January 2018

1 reference

Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants

21 January 2018

1 reference

Human Immunodeficiency Virus Seroconversion and Evolution of the Hepatitis C Virus Quasispecies

21 January 2018

1 reference

Does HIV tat protein also regulate genes of other viruses present in HIV infection?

21 January 2018

1 reference

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs

21 January 2018

1 reference

The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men.

21 January 2018

1 reference

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

21 January 2018

1 reference

The CCR5Delta32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment

21 January 2018

1 reference

Chronic hepatitis B virus infection: treatment strategies for the next millennium

21 January 2018

1 reference

Viral escape and the failure of cellular immune responses

21 January 2018

1 reference

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

21 January 2018

1 reference

Apoptosis and viral hepatitis

21 January 2018

1 reference

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

21 January 2018

1 reference

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy

21 January 2018

1 reference

21 January 2018

The hepatitis B virus

1 reference

The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice

21 January 2018

1 reference

Global programme for control of hepatitis B infection

21 January 2018

1 reference

Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen

21 January 2018

1 reference

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

21 January 2018

1 reference

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

21 January 2018

1 reference

Oral treatment for hepatitis B gets approval in the United States

21 January 2018

1 reference

A preliminary trial of lamivudine for chronic hepatitis B infection

21 January 2018

1 reference

Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study

21 January 2018

1 reference

Lamivudine as initial treatment for chronic hepatitis B in the United States

21 January 2018

1 reference

Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B

21 January 2018

1 reference

Lamivudine treatment of chronic hepatitis B

21 January 2018

1 reference

Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value

21 January 2018

1 reference

HIV nucleoside analogues: new adverse effects on mitochondria?

21 January 2018

1 reference

Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis

21 January 2018

1 reference

Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group

21 January 2018

1 reference

Efficacy and safety of alpha-interferon treatment for chronic hepatitis C in HIV-infected patients. HIV-Hepatitis Spanish Study Group

21 January 2018

1 reference

Rapid decline of CD4+ cells after IFN alpha treatment in HIV-1 infection

21 January 2018

1 reference

Red fingers syndrome in patients with HIV and hepatitis C infection

21 January 2018

1 reference

Identification and quantitation of HIV-1 in the liver of patients with AIDS

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.323

1 reference

1 August 2017

1 reference